Cencora Quarterly Cash Flow Statement
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cencora free cash flow
In the quarter ended Jun 30, 2026, Cencora generated $2.65 billion of operating cash flow and spent $226.0 million on capital expenditures. That left free cash flow of $2.43 billion, a free-cash-flow margin of 2.9% of revenue. Cencora returned $1.12 billion to shareholders: $116.6 million in dividends and $1.00 billion in share repurchases, equal to 46% of free cash flow.
Free cash flow covered dividend payments 20.8 times.
Summary generated from market data by MetaCap's automated system. Methodology
Cencora cash flow statement (quarterly)
| Quarter (USD) | Q3 20262026-06-30 | Q2 20262026-03-31 | Q1 20262025-12-31 | Q4 20252025-09-30 | Q3 20252025-06-30 | Q2 20252025-03-31 | Q1 20252024-12-31 | Q4 20242024-09-30 | Q3 20242024-06-30 | Q2 20242024-03-31 | Q1 20242023-12-31 | Q4 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 776.67M | 1.63B | 566.13M | -333.07M | 689.75M | 717.42M | 493.72M | 7.47M | 487.59M | 421.20M | 603.01M | 348.98M |
| Net Income growth (YoY) | +12.60% | +127.14% | +14.67% | -4561.17% | +41.46% | +70.32% | -18.12% | -97.86% | +1.75% | -1.64% | +26.64% | +16.84% |
| Depreciation & Amortization | 269.50M | 249.29M | 260.40M | 258.77M | 254.00M | 259.82M | 278.49M | 111.25M | 114.28M | 112.57M | 110.11M | 111.48M |
| Stock-Based Compensation | 28.73M | 28.00M | 66.05M | 25.94M | 23.18M | 28.45M | 70.38M | 34.59M | 22.18M | 28.16M | 63.08M | 24.93M |
| Change in Working Capital | 1.64B | 559.42M | -3.39B | 2.72B | -819.75M | 2.30B | -3.55B | 510.01M | 1.63B | -1.52B | 237.31M | 1.43B |
| Operating Cash Flow | 2.65B | 1.34B | -2.31B | 3.13B | 109.25M | 3.35B | -2.72B | 1.00B | 2.48B | -878.44M | 885.16M | 1.83B |
| Capital Expenditures | -226.04M | -165.62M | -119.38M | -249.81M | -183.22M | -129.06M | -105.89M | -182.32M | -117.88M | -112.75M | -74.22M | -175.50M |
| Investing Cash Flow | -240.15M | -4.87B | -299.31M | -321.94M | -234.69M | -4.08B | -343.04M | -241.88M | -143.92M | -166.49M | -65.80M | -183.44M |
| Dividends Paid | -116.59M | -117.46M | -126.52M | -107.51M | -107.49M | -111.19M | -110.89M | -100.94M | -102.53M | -107.00M | -105.69M | -98.34M |
| Share Repurchases | -1.00B | 0 | 0 | -71.00K | 0 | -50.00M | -385.40M | -504.98M | -550.01M | -50.84M | -385.53M | -273.51M |
| Debt Issued | 39.33M | 4.54B | 107.72M | 0 | 1.19B | 1.51B | 1.81B | 0 | 53.38M | 544.88M | 90.07M | — |
| Debt Repaid | -719.65M | -217.78M | -131.71M | -517.20M | -214.85M | -503.62M | -44.95M | -3.27M | -539.40M | -36.22M | -83.64M | -51.76M |
| Financing Cash Flow | -1.77B | 3.98B | 43.20M | -683.78M | 215.48M | -491.74M | 3.21B | -957.26M | -1.15B | 323.17M | -551.67M | -407.01M |
| Net Change in Cash | 628.70M | 427.57M | -2.59B | 2.12B | 96.76M | -1.22B | 97.09M | -178.52M | 1.19B | -750.98M | 283.23M | 1.20B |
| Free Cash Flow | 2.43B | 1.17B | -2.42B | 2.88B | -73.97M | 3.22B | -2.82B | 818.05M | 2.36B | -991.20M | 810.94M | 1.65B |
This table shows 12 quarterly periods of Cencora's cash flow statement, from Q3 2026 back to Q4 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow COR's reporting calendar. What is a cash flow statement?